105326-65-6

Basic information

• Product Name: 3-[(2-quinolinyl)methoxy]benzenamine
• Synonyms: 3-[(2-quinolinyl)methoxy]benzenamine
• CAS NO: 105326-65-6
• Molecular Weight: 250.3
• Mol File: 105326-65-6.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 3-[(2-quinolinyl)methoxy]benzenamine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(2-quinolinyl)methoxy]benzenamine(105326-65-6)
• EPA Substance Registry System: 3-[(2-quinolinyl)methoxy]benzenamine(105326-65-6)

Safety Data

• Hazardous Substances Data: 105326-65-6(Hazardous Substances Data)

Upstream product

• 554-84-7 meta-nitrophenol 
• 4377-41-7 2-Chloromethylquinoline 
• 621-42-1 meta-hydroxyacetanilide 
• 3747-74-8 2-(chloromethyl)quinoline monohydrochloride 
• 91-63-4 2-methylquinoline 
• 5632-15-5 quinolin-2-ylmethylbromide 
• 591-27-5 m-Hydroxyaniline 
• 111974-54-0 3-<(2-quinolinyl)methoxy>nitrobenzene 

Downstream Products

• 119481-21-9 C₂₂H₂₆N₂O₅S₂ 
• 102649-98-9 N-[3-(Quinolin-2-ylmethoxy)-phenyl]-succinamic acid ethyl ester 
• 119481-24-2 C₁₈H₁₉N₃O₃S 
• 102649-84-3 4-{[3-(2-quinolinylmethoxy)phenyl]amino}-4-oxobutanoic acid methyl ester 
• 146680-10-6 3-(2'-Quinolylmethoxy)-N,N-di-(3-fluorobenzyl)aniline 
• 111974-60-8 1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]methanesulfonamide 
• 135500-19-5 (2R,3R;2S,3S)-3-[3-(2-Quinolylmethoxy)-anilino]-2-hydroxy-3-phenyl propionic acid, sodium salt 
• 135334-37-1 (S,R)-2-[3-(2-quinolylmethyloxy)-anilino]-2-phenyl acetic acid 
• 102649-86-5 4-{[3-(2-quinolinylmethoxy)phenyl]amino}-4-oxobutanoic acid 
• 119503-20-7 <<<3-(2-quinolinylmethoxy)phenyl>amino>sulfonyl>acetic acid 
• 105349-78-8 N-benzyl-3-(2-quinolinylmethyloxy)phenylamine 
• 111974-55-1 N-[3-[(2-quinolinyl)methoxy]phenyl]ethane sulfonamide 
• 119481-42-4 N-[3-(Quinolin-2-ylmethoxy)-phenyl]-3,5-bis-trifluoromethyl-benzenesulfonamide 
• 119481-41-3 N-[3-(Quinolin-2-ylmethoxy)-phenyl]-4-trifluoromethyl-benzenesulfonamide 

Relevant articles and documents

DRUG DISCHARGE PUMP INHIBITORS

A medicament for preventive and/or therapeutic treatment of a microbial infection having an activity of eliminating resistance of a microorganism with acquired resistance to an antimicrobial agent, which comprises as an active ingredient a compound represented by the following general formula (I), a physiologically acceptable salt thereof, or a hydrate thereof: wherein R1 and R2 independently represent hydrogen atom, a halogen atom, carboxyl group and the like; J1 represents a 5- or 6-membered heteroaromatic ring; W1 represents -CH=CH-, -C≡C-, -CH2CH2- and the like; A1 represents phenylene group, pyridinediyl group, furandiyl group and the like; G1 represents oxygen atom, carbonyl group, ethynyl group and the like; p represents an integer of from 0 to 3; G2 represents phenylene group, furandiyl group, tetrahydrofurandiyl group and the like; G3 represents -CH2- or single bond; m and n represent an integer of 0 or 1; and Q1 represents an acidic group.

Discovery of OT4003, a novel, potent, and orally active cys-LT1 receptor antagonist

The present paper describes the structural modifications leading to the discovery of a new series of quinoline-containing cys-LT1 receptor (LTD4 receptor) antagonists. A structural optimization with respect to the in vitro receptor b

LEUKOTRIENE-INHIBITING SUBSTITUTED (QUINOLIN-2-YL-METHOXY)PHENYL-N,N'-SULPHONYLUREAS AND USE THEREAS

Lipoxygenase-inhibiting and leukotriene-inhibiting substituted (quinolin-2-yl-methoxy)phenyl-N,N'-sulphonylureas of the formula and physiologically acceptable salts thereof